Exelixis Inc (NAS:EXEL)
$ 56.51 -0.60 (-1.05%) Market Cap: 14.20 Bil Enterprise Value: 13.59 Bil PE Ratio: 18.77 PB Ratio: 7.40 GF Score: 92/100

Exelixis Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 01:15AM GMT
Release Date Price: $44.08 (+0.05%)
Matthew Bannon
JPMorgan Chase & Co - Analyst

All right. Welcome back to the 44th Annual JPMorgan Healthcare Conference. My name is Matt Bannon, and I'm a banker here at JPM. I am very pleased to be introducing our final presenting company of the day, Exelixis. And presenting on behalf of the company, we'll have President and CEO, Michael Morrissey.

Before I turn it over to Michael, I'll remind folks that this is a Q&A session. (Event Instructions) So without further ado, Michael?

Michael Morrissey
Exelixis Inc - President, Chief Executive Officer, Director

All right. Fantastic. Thank you, and good evening, everybody. Thanks for hanging in there for one last session. I've been talking since 7:30 this morning. Meeting has been great, and I want to thank the JPMorgan team for the invitation and for the great, full packed schedule of one-on-one meetings. It's just a great day, great way to start the year. And we're excited to be able to tell you a little bit about Exelixis, where we've been in '25 and where we're going in 2026. So I'm going to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot